发明名称 |
COMBINATION OF RO5503781, CAPECITABINE AND OXALIPLANTIN FOR CANCER THERAPY |
摘要 |
The present application discloses pharmaceutical products comprising a) as a first component a pharmaceutical composition comprising as an active ingredient a therapeutically effective amount of the compound of formula (A) or a pharmaceutically acceptable salt, ester or prodrug of said compound; b) a second component comprising a pharmaceutical composition comprising a therapeutically effective amount of capecitabine; and c) a third component comprising a pharmaceutical composition comprising a therapeutically effective amount of oxaliplatin. The application also discloses methods for the treatment of cancer using said products, as well as kits containing said products. |
申请公布号 |
CA2912743(A1) |
申请公布日期 |
2014.12.24 |
申请号 |
CA20142912743 |
申请日期 |
2014.06.16 |
申请人 |
F. HOFFMANN-LA ROCHE AG |
发明人 |
HIGGINS, BRIAN;NICHOLS, GWEN;PACKMAN, KATHRYN E. |
分类号 |
A61K31/555;A61K31/40;A61K31/513;A61K31/7068;A61P35/00 |
主分类号 |
A61K31/555 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|